Table 1.
Characteristics of Medicare and non-Medicare lung transplant recipients
| Medicare |
Non-Medicare |
P Value | |
|---|---|---|---|
| (n = 3,128) | (n = 6,598) | ||
| Age, yr | 63 (55–67) | 56 (46–62) | <0.0001 |
| Male, n (%) | 1,839 (58.8) | 3,879 (58.8) | 0.9992 |
| Ethnicity, n (%) | 0.0210 | ||
| White | 2,677 (85.6) | 5,514 (83.6) | |
| Black | 250 (8.0) | 589 (8.9) | |
| Hispanic | 143 (4.6) | 357 (5.4) | |
| Asian | 31 (1.0) | 97 (1.5) | |
| Other | 27 (0.9) | 41 (0.6) | |
| Diagnosis, n (%) | <0.0001 | ||
| Group A, COPD | 1,331 (42.7) | 1,978 (30.2) | |
| Group B, pulmonary hypertension | 103 (3.3) | 225 (3.4) | |
| Group C, cystic fibrosis | 293 (9.4) | 945 (14.4) | |
| Group D, pulmonary fibrosis | 1,388 (44.6) | 3,411 (52.0) | |
| Bilateral transplant type, n (%) | 1,822 (58.3) | 4,560 (69.1) | <0.0001 |
| Life support, n (%) | 173 (5.5) | 469 (7.1) | 0.0034 |
| Lung allocation score, n (%) | <0.0001 | ||
| <35 | 1,096 (35.0) | 1,855 (28.1) | |
| 35–39 | 760 (24.3) | 1,635 (24.8) | |
| 40–49 | 679 (21.7) | 1,574 (23.9) | |
| ≥50 | 593 (19.0) | 1,534 (23.2) | |
| Transplant center volume, n (%) | 0.0001 | ||
| Low | 604 (19.3) | 1,285 (19.5) | |
| Intermediate | 800 (25.6) | 1,944 (29.5) | |
| High | 1,724 (55.1) | 3,369 (51.0) |
Definition of abbreviation: COPD = chronic obstructive pulmonary disease.